Table of Contents

2019-2024 Global Human Microbiome Modulators Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Modulators Market Size 2014-2024
2.1.2 Human Microbiome Modulators Market Size CAGR by Region
2.2 Human Microbiome Modulators Segment by Type
2.2.1 Probiotics and Creams
2.2.2 Prebiotics and Dietary Supplements
2.2.3 Drugs
2.3 Human Microbiome Modulators Market Size by Type
2.3.1 Global Human Microbiome Modulators Market Size Market Share by Type (2014-2019)
2.3.2 Global Human Microbiome Modulators Market Size Growth Rate by Type (2014-2019)
2.4 Human Microbiome Modulators Segment by Application
2.4.1 Digestive Health
2.4.2 Immune Health
2.4.3 Oral Health
2.4.4 Others
2.5 Human Microbiome Modulators Market Size by Application
2.5.1 Global Human Microbiome Modulators Market Size Market Share by Application (2014-2019)
2.5.2 Global Human Microbiome Modulators Market Size Growth Rate by Application (2014-2019)

3 Global Human Microbiome Modulators by Players
3.1 Global Human Microbiome Modulators Market Size Market Share by Players
3.1.1 Global Human Microbiome Modulators Market Size by Players (2017-2019)
3.1.2 Global Human Microbiome Modulators Market Size Market Share by Players (2017-2019)
3.2 Global Human Microbiome Modulators Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion

4 Human Microbiome Modulators by Regions
4.1 Human Microbiome Modulators Market Size by Regions
4.2 Americas Human Microbiome Modulators Market Size Growth
4.3 APAC Human Microbiome Modulators Market Size Growth
4.4 Europe Human Microbiome Modulators Market Size Growth
4.5 Middle East and Africa Human Microbiome Modulators Market Size Growth

5 Americas
5.1 Americas Human Microbiome Modulators Market Size by Countries
5.2 Americas Human Microbiome Modulators Market Size by Type
5.3 Americas Human Microbiome Modulators Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Microbiome Modulators Market Size by Countries
6.2 APAC Human Microbiome Modulators Market Size by Type
6.3 APAC Human Microbiome Modulators Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Human Microbiome Modulators by Countries
7.2 Europe Human Microbiome Modulators Market Size by Type
7.3 Europe Human Microbiome Modulators Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Human Microbiome Modulators by Countries
8.2 Middle East and Africa Human Microbiome Modulators Market Size by Type
8.3 Middle East and Africa Human Microbiome Modulators Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Human Microbiome Modulators Market Forecast
10.1 Global Human Microbiome Modulators Market Size Forecast (2019-2024)
10.2 Global Human Microbiome Modulators Forecast by Regions
10.2.1 Global Human Microbiome Modulators Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Human Microbiome Modulators Forecast by Type
10.8 Global Human Microbiome Modulators Forecast by Application

11 Key Players Analysis
11.1 Bayer
11.1.1 Company Details
11.1.2 Human Microbiome Modulators Product Offered
11.1.3 Bayer Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Bayer News
11.2 BioGaia
11.2.1 Company Details
11.2.2 Human Microbiome Modulators Product Offered
11.2.3 BioGaia Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 BioGaia News
11.3 Chr. Hansen Holding
11.3.1 Company Details
11.3.2 Human Microbiome Modulators Product Offered
11.3.3 Chr. Hansen Holding Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Chr. Hansen Holding News
11.4 DowDuPont
11.4.1 Company Details
11.4.2 Human Microbiome Modulators Product Offered
11.4.3 DowDuPont Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 DowDuPont News
11.5 Ingredion
11.5.1 Company Details
11.5.2 Human Microbiome Modulators Product Offered
11.5.3 Ingredion Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Ingredion News
11.6 ISOThrive
11.6.1 Company Details
11.6.2 Human Microbiome Modulators Product Offered
11.6.3 ISOThrive Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 ISOThrive News
11.7 Jarrow Formulas
11.7.1 Company Details
11.7.2 Human Microbiome Modulators Product Offered
11.7.3 Jarrow Formulas Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Jarrow Formulas News
11.8 DSM
11.8.1 Company Details
11.8.2 Human Microbiome Modulators Product Offered
11.8.3 DSM Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 DSM News
11.9 Lallemand
11.9.1 Company Details
11.9.2 Human Microbiome Modulators Product Offered
11.9.3 Lallemand Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Lallemand News
11.10 Sanofi
11.10.1 Company Details
11.10.2 Human Microbiome Modulators Product Offered
11.10.3 Sanofi Human Microbiome Modulators Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Sanofi News

12 Research Findings and Conclusion